Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint? Meyers M, Mouna O, Langouo M. Curr Opin Oncol 2024 Dec 30. doi: 10.1097/CCO.0000000000001119.

Read + Share

Amedeo Smart

Independent Medical Education

Meyers M, Mouna O, Langouo M. Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint? Curr Opin Oncol 2024 Dec 30. doi: 10.1097/CCO.0000000000001119.
PMID: 39869008